Company & Sponsor Intelligence

McGill University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting2

Completed5

Countries1

Therapeutic footprint

adhdalzheimersautismdepressionpain_neuropathyparkinsonsstroke

Indexed studies

NCT03402919Comprehensive Assessment of Neurodegeneration and Dementia
alzheimers · CanadaRECRUITING

NCT01374100Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy
depression · CanadaNA

NCT00483106Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
adhd · CanadaPHASE4

NCT04300348Improving Walking With Heel-To-Toe Device
parkinsons · CanadaNA

NCT06994559Music as an Adjunct to Ketamine Therapy for Chronic Pain
pain_neuropathy · CanadaNA

NCT02725853Enhancing Recovery of Arm Movement in Stroke Patients
stroke · CanadaNA

NCT02439671Transition Support Program for Young Adults With Autism Spectrum Disorders
autism · CanadaNA

NCT05076747Exercise and Genotype in Sub-acute Stroke
stroke · CanadaNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →